Trial Profile
The effects of pioglitazone vs metformin on depression and hormonal changes in polycystic ovarian syndrome : a randomized clinical trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2013
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Metformin
- Indications Major depressive disorder; Polycystic ovary syndrome
- Focus Pharmacodynamics
- 22 Aug 2013 Status changed from recruiting to completed.
- 01 Jun 2013 Primary endpoint 'Hamilton-Depression-Rating-Scale' has been met.
- 01 Oct 2011 New trial record